Biotech Growth Trust (The) (BIOG) Ordinary 25p
22.00p
(2.84%)
- Add to watchlist
- Create an alert
- This stock can be held in a
22.00p
(2.84%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
22.00p
(2.84%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
794.00p
798.00p
1,015.00p
928.50
776.00p
760.00p
662.00p
-12.44%
42.00p (5.13%) Previous:
42.00p
56,401
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 2.65% | 1 year 1Y | 11.82% |
|---|---|---|---|
| 1 month 1M | 17.45% | 2 years 2Y | 10.7% |
| 3 months 3M | 17.45% | 3 years 3Y | 6.23% |
| 6 months 6M | 9.6% | 5 years 5Y | 1.17% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | NASDAQ Biotechnology TR USD |
|---|---|
| Annual management charge: | 0.65% of Net Assets |
| Performance fee: | Yes |
| Ongoing charge: | 1.05% |
| Dividend yield: | n/a |
| Dividend frequency: | Annually |
| Total assets: | £409m |
| Gross gearing: | 111% |
| Market capitalisation:Market cap.: | £321m |
| Shares in issue: | 39.21 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | 928.50 |
|---|---|
| Latest actual NAV: | 939.19 |
| Latest actual NAV date: | 26 March 2020 |
| Premium/Discount: | -12.44% |
| 12m average Premium/Discount: | -8.30% |
| NAV frequency: | Daily |
Recent trade data is temporarily unavailable. We will be replacing it shortly, however in the meantime the information is available on the London Stock Exchange website.
| Security | Weight |
|---|---|
| Vertex Pharmaceuticals Inc | 9.91% |
| Amgen Inc | 5.25% |
| Neurocrine Biosciences Inc | 5.22% |
| Mirati Therapeutics Inc | 5.00% |
| CRISPR Therapeutics AG CHF0.03 | 4.88% |
| Biogen Inc | 4.55% |
| Sarepta Therapeutics Inc | 4.24% |
| Gilead Sciences Inc | 4.01% |
| Alexion Pharmaceuticals Inc | 3.77% |
| MeiraGTx Holdings PLC | 3.46% |
| Sector | Weight |
|---|---|
| Healthcare | 99.27% |
| Country | Weight |
|---|---|
| United States | 79.41% |
| China | 5.75% |
| Switzerland | 4.88% |
| United Kingdom | 3.92% |
| Canada | 3.11% |
| Luxembourg | 1.82% |
| Germany | 0.38% |
Key Dates
| Launch date: | 23 June 1997 |
|---|---|
| Financial year end: | March |
| Next AGM: | July 2020 |
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.